Jianliang Yang
-
- Lymphoma Diagnosis and Treatment 60
- Oncology top 10%
- Viral-associated cancers and disorders 33
- CAR-T cell therapy research 12
- Lung Cancer Research Studies 7
- Cancer Immunotherapy and Biomarkers 6
- Urology top 5%
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 18
- Gastroenterology top 10%
-
- Lung Cancer Treatments and Mutations 10
-
- CNS Lymphoma Diagnosis and Treatment 7
- Co-authors
- Xiaohui HeYuankai ShiShengyu ZhouYan QinLin GuiChanggong ZhangSheng YangPeng Liu
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Jianliang Yang
84 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 81
- Pathology and Forensic Medicine 488
- Oncology 448
- Urology 88
- Genetics 111
- Gastroenterology 52
Countries citing papers authored by Jianliang Yang
This map shows the geographic impact of Jianliang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianliang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianliang Yang more than expected).
Fields of papers citing papers by Jianliang Yang
This network shows the impact of papers produced by Jianliang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianliang Yang. The network helps show where Jianliang Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianliang Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 1 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2019 | 62 | |
| 16 | 2018 | 12 | |
| 17 | 2017 | 15 | |
| 18 | 2013 | 7 | |
| 19 | 2008 | 68 | |
| 20 | 2000 | 172 |
About Jianliang Yang
Jianliang Yang is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 89 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (60 papers), Viral-associated cancers and disorders (33 papers), Chronic Lymphocytic Leukemia Research (18 papers), CAR-T cell therapy research (12 papers), Lung Cancer Treatments and Mutations (10 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (488 citations), Oncology (448 citations) and Urology (88 citations). Jianliang Yang has collaborated with scholars based in China, United States and India. Frequent co-authors include Xiaohui He, Yuankai Shi, Shengyu Zhou, Yan Qin, Lin Gui, Changgong Zhang, Sheng Yang, Peng Liu, Mei Dong and Leona Ling. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Hematology, Leukemia Research and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.